Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $76.1400 (0.42%) ($76.0900 - $76.1400) on Fri. Jan. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.68% (three month average) | RSI | 46 | Latest Price | $76.1400(0.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.8% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(58%) IBUY(57%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -3.84% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) TBT(-7%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.84% (StdDev 7.68%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $77.53 | 5 Day Moving Average | $75.44(0.93%) | 10 Day Moving Average | $78.57(-3.09%) | 20 Day Moving Average | $77.53(-1.79%) | To recent high | -16.2% | To recent low | 174.7% | Market Cap | $4.729b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |